Is there really a link between benzodiazepine use and the risk of dementia?
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Several studies have highlighted an increased risk of dementia in benzodiazepine users. As dementia incidence and benzodiazepine use are both high, particularly in the elderly, even a moderate increase in this risk would induce a tremendous number of cases and have a major public health impact. AREAS COVERED: The aim of this article was to systematically review published observational studies having assessed the relation between benzodiazepine use and dementia, to assess and rank their quality and to provide a balanced opinion about the plausibility of a causal relationship. EXPERT OPINION: Out of the ten studies retrieved, nine reported an increased risk of dementia in benzodiazepine users. The risk increased with cumulative dose and treatment duration and when long-acting molecules were used. Even if the causal nature of this association remains unproved, the reviewed material provides arguments for evoking a causal link. Further research would be necessary to elucidate the mechanism of this effect, if any, to evaluate the risk of exposure in younger population and the influence of risk factors such as depression. In any case, the body of evidence seems sufficient for avoiding prescriptions or renewals that are not fully justified and indiscriminate long-term use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
What is cognitive reserve? Theory and research application of the reserve concept
STERN, Y. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702813248 · Cited by 3,951
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907 · cited 1×
“2 Evaluation of the quality of the study We used the Newcastle-Ottawa scale, specifically developed for non-randomized studies [17] and considered as one of the two most useful tools for systematic reviews and meta-analysis [18].”
MethodLyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., & DeKosky, S. (2002) · JAMA · doi:10.1001/jama.288.12.1475 · Cited by 2,049 · cited 2×
“This type of study would have another spin-off: to assess the role of midlife anxiety, sleep disorders and depression suspected to be early risk factors and/or prodromal symptoms for dementia [11,15,16].”
BackgroundDepression and dementia: cause, consequence or coincidence?
Bennett, S., & Thomas, A. J. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.05.009 · Cited by 569
Tannenbaum, C., Paquette, A., Hilmer, S., Holroyd-Leduc, J., & Carnahan, R. (2012) · Drugs & Aging · doi:10.1007/bf03262280 · Cited by 241
Dell’osso, B., & Lader, M. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2011.11.003 · Cited by 210 · cited 1×
“Their use is constantly high in the elderly, ranges between 7 and 43% across countries [43-46] and is often chronic and seldom justified.”
BackgroundBenzodiazepines and Injurious Falls in Community Dwelling Elders
Pariente, A., Dartigues, J.-F., Benichou, J., Letenneur, L., Moore, N., & Fourrier-Réglat, A. (2008) · Drugs & Aging · doi:10.2165/00002512-200825010-00007 · Cited by 172 · cited 1×
“Apart from other risks such as falls and fractures [6], the putative deleterious effects of chronic consumption of these drugs on cognitive functions have been advanced, particularly in the elderly owing to their high neurocognitive vulnerability [7].”
BackgroundFourrier, A., Letenneur, L., Dartigues, J., Moore, N., & Bégaud, B. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280100326 · Cited by 158 · cited 2×
“2 Comparability If cases and controls were made comparable for variables such as age and sex in all studies, some putative confounders, that is, strongly linked to benzodiazepine use [31] and dementia [32], were not controlled for by several studies such as educational level (Billioti de Gage et al.”
BackgroundSelf-citationUsage of benzodiazepines: A review
Donoghue, J., & Lader, M. (2010) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651500903447810 · Cited by 156 · cited 1×
“Their use is constantly high in the elderly, ranges between 7 and 43% across countries [43-46] and is often chronic and seldom justified.”
Background
Cited by
Craske, M. G., & Stein, M. B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30381-6 · Cited by 640
Brandt, J., & Leong, C. (2017) · Drugs in R&D · doi:10.1007/s40268-017-0207-7 · Cited by 356
“Of the studies, nine reported an increased risk of dementia from benzodiazepines [122].”
BackgroundMethodInfluentialStein, M. B., & Sareen, J. (2015) · New England Journal of Medicine · doi:10.1056/nejmcp1502514 · Cited by 314
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Benzodiazepines and sleep architecture: a systematic review
Sousa Martins Silva, A., de Mendonça, F. M. R., de Mendonça, G. P. R. R., Souza, L. C., Galvão, L. P., Paiva, H. S., de Azevedo Marques Périco, C., Torales, J., Ventriglio, A., & Maurício Castaldelli-Maia, J. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210618103344 · Cited by 149
Metadata
- Authors
- Billioti de Gage, S., Pariente, A., & Bégaud, B.
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa Healthcare
- Published
- 2015-02-18
- Volume
- 14
- Issue
- 5
- Pages
- 733-747
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W2092911825
- Cited by
- 108
- References
- 11
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Is there really a link between benzodiazepine use and the risk of dementia? https://app.cochat.ai/papers/10.1517/14740338.2015.1014796
- The paper
- Billioti de Gage, S., Pariente, A., & Bégaud, B. (2015). Is there really a link between benzodiazepine use and the risk of dementia? Expert Opinion on Drug Safety. https://doi.org/10.1517/14740338.2015.1014796
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.